Arkansas Children's provides right-sized care for your child. U.S. News & World Report has ranked Arkansas Children's in seven specialties for 2022-2023.
Sign up online to quickly and easily manage your child's medical information and connect with us whenever you need.
We're focused on improving child health through exceptional patient care, groundbreaking research, continuing education, and outreach and prevention.
Our ERs are staffed 24/7 with doctors, nurses and staff who know kids best – all trained to deliver right-sized care for your child in a safe environment.
Arkansas Children's provides right-sized care for your child. U.S. News & World Report has ranked Arkansas Children's in seven specialties for 2022-2023.
Find health tips, patient stories, and news you can use to champion children.
Our flu resources and education information help parents and families provide effective care at home.
We are dedicated to caring for children, allowing us to uniquely shape the landscape of pediatric care in Arkansas.
Our researchers are driven by their limitless curiosity to discover new and better ways to make these children better today and healthier tomorrow.
We're focused on improving child health through exceptional patient care, groundbreaking research, continuing education, and outreach and prevention.
Then we're looking for you! Work at a place where you can change lives...including your own.
When you give to Arkansas Children's, you help deliver on our promise of a better today and a healthier tomorrow for the children of Arkansas and beyond
The gift of time is one of the most precious gifts you can give. You can make a difference in the life of a sick child.
Support and participate in this advocacy effort on behalf of Arkansas’ youth and our organization.
The Burdine Laboratory is focused on developing novel clinical therapeutics for pediatric transplant patients. Most children that require organ transplantation will eventually need retransplantation in their teenage or early adult lives due to chronic allograft rejection, the most common cause of graft loss. My laboratory has developed a small molecule strategy using commercially available DNA-PK inhibitors to block both humoral and cell mediated immunity which cause organ rejection. Our lab is currently focused on preclinical studies of this drug as a transplant immunosuppressant, a strategy that will reduce potential side effects and financial burden. In addition, we are investigating mechanisms used by DNA-PKcs as a master regulator of the immune system and how that might influence cancer and autoimmune diseases.
View a complete list of Dr. Burdine's published work in My Bibliography.
See Publications